Lycia Therapeutics Insider Trades

LYCA

Track insider trading activity from Lycia Therapeutics executives and directors. See which insiders are buying and selling LYCA stock.

Trades Last 12 Months

LYCA Price

All Insider Trades for Lycia Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $180M 6,825,233 shares
Last Trade
Oct 27, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.06M 39,796 shares
$26.62
$26.40
Fischer Laurent Director
Holding Value $528k 20,000 shares
Last Trade
Oct 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Henderson Jane Director
Holding Value $528k 20,000 shares
Last Trade
Oct 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Holding Value $528k 20,000 shares
Last Trade
Oct 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Bachrodt Amy 10% owner, Chief Financial Officer
Holding Value $10.6M 399,746 shares
Last Trade
Aug 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Staben Steven 10% owner, Chief Scientific Officer
Holding Value $2.93M 110,896 shares
Last Trade
Aug 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Touami Sofia Chief Business Officer
Holding Value $1.82M 68,755 shares
Last Trade
Aug 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Trombley Aetna Wun 10% owner, President And CEO
Holding Value $11.7M 443,586 shares
Last Trade
Aug 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40
Lee Chin Hyok 10% owner, Chief Medical Officer
Holding Value $1.93M 73,191 shares
Last Trade
Aug 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$26.40

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up